Scarica l'app Stockscreener
4.05
2.88%
-0.12
Dopo l'orario di chiusura:
4.05
Precedente Chiudi:
$4.17
Aprire:
$4.23
Volume 24 ore:
92,540
Relative Volume:
0.59
Capitalizzazione di mercato:
$21.32M
Reddito:
-
Utile/perdita netta:
$-21.21M
Rapporto P/E:
-0.1242
EPS:
-32.6
Flusso di cassa netto:
$-16.86M
1 W Prestazione:
-27.81%
1M Prestazione:
-6.90%
6M Prestazione:
-11.38%
1 anno Prestazione:
+65.64%
Intervallo 1D:
$4.02
$4.25
Intervallo di 1 settimana:
$4.01
$5.5563
Portata 52W:
$1.8001
$20.83
Cingulate Inc Stock (CING) Company Profile
Nome
Cingulate Inc
Settore
Industria
Telefono
(913) 942-2300
Indirizzo
1901 W. 47TH PLACE, KANSAS CITY
Confronta CING con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CING
Cingulate Inc
|
4.05 | 21.46M | 0 | -21.21M | -16.86M | -32.60 |
|
VRTX
Vertex Pharmaceuticals Inc
|
374.46 | 93.98B | 11.42B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
435.00 | 57.53B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.94 | 59.67B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
638.90 | 40.50B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
289.75 | 34.26B | 3.81B | -644.79M | -669.77M | -6.24 |
Cingulate Inc Stock (CING) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-10 | Iniziato | ROTH MKM | Buy |
| 2023-12-22 | Downgrade | Laidlaw | Buy → Hold |
Cingulate Inc Borsa (CING) Ultime notizie
Cingulate terminates COO one day after submitting drug for FDA approval - The Business Journals
Analyzing drawdowns of Cingulate Inc. with statistical toolsTrade Ideas Based on Fundamental Metrics - Newser
Why Cingulate Inc. Equity Warrant is moving todayFree Chart Driven High Reward Trading Setup - Newser
Identifying reversal signals in Cingulate Inc. Equity WarrantAI Powered Buy Point Forecast Planner - Newser
How to read the order book for Cingulate Inc.Free Trade Scanner With Buy Zone Alerts - Newser
Smart tools for monitoring Cingulate Inc.’s price actionFree Short Term Setup With Predictive Chart - Newser
Does Cingulate Inc. Equity Warrant show high probability of reboundFree Triple Return Setup with Risk Control - Newser
Is Cingulate Inc. Equity Warrant reversing from oversold territoryReal Time Stock Movement and Alerts - Newser
Understanding Cingulate Inc.’s price movementFree Pattern Alert With ROI Driven Strategy - Newser
What technical models suggest about Cingulate Inc.’s comebackTechnical Insight Guide for Safer Trades - Newser
Using R and stats models for Cingulate Inc. Equity Warrant forecastingSwing Reversal Forecast Based on Patterns - Newser
Using data filters to optimize entry into Cingulate Inc. Equity WarrantEntry Timing with Downside Risk Analysis - Newser
Cingulate CEO tells Roth COO departure has no meaningful impact on CTx-1301 - TipRanks
What momentum shifts mean for Cingulate Inc.Swing Trade Timing with Daily Forecast - Newser
Cingulate Inc.’s Strategic Partnerships and NDA Submission Drive Buy Rating - TipRanks
Cingulate submits CTx-1301 NDA to FDA - TipRanks
Cingulate Inc Submits NDA for ADHD Treatment - TipRanks
Cingulate submits NDA for ADHD treatment to FDA By Investing.com - Investing.com Nigeria
Cingulate submits NDA for ADHD treatment to FDA - Investing.com
Cingulate Submits New Drug Application for ADHD Asset CTx-1301 to FDA - AInvest
Cingulate Submits NDA for CTx-1301, ADHD Treatment with Extended-Release Tablet - AInvest
Cingulate Submits New Drug Application to FDA for Lead ADHD Asset CTx-1301 - GlobeNewswire
META Gets Huge Upgrades: How High Analysts Think Shares Could Go - The Globe and Mail
How many analysts rate Cingulate Inc. Equity Warrant as a “Buy”Unlock exclusive stock market insights - Jammu Links News
Cingulate Inc. Stock Analysis and ForecastDiscover breakthrough investment opportunities - Jammu Links News
What is Cingulate Inc. company’s growth strategyRapid market gains - Jammu Links News
How does Cingulate Inc. Equity Warrant generate profit in a changing economyMaximize returns with smart investment plans - Jammu Links News
How many analysts rate Cingulate Inc. as a “Buy”Maximize portfolio growth with expert advice - Jammu Links News
How strong is Cingulate Inc. company’s balance sheetMaximize portfolio growth with strategic plans - Jammu Links News
When is Cingulate Inc. stock expected to show significant growthMarket-leading capital gains - Jammu Links News
What drives Cingulate Inc. stock priceRapid wealth multiplication - Jammu Links News
Why is Cingulate Inc. stock attracting strong analyst attentionFree Stock Index Interpretation - Jammu Links News
What analysts say about Cingulate Inc. Equity Warrant stockInvest confidently with real-time market updates - Jammu Links News
What are the latest earnings results for Cingulate Inc. Equity WarrantBuild a diversified portfolio for steady profits - Jammu Links News
Is it the right time to buy Cingulate Inc. stockUnlock powerful market trend analysis - Jammu Links News
What institutional investors are buying Cingulate Inc. Equity Warrant stockFree Investment Timing Strategies - Jammu Links News
What is Cingulate Inc. Equity Warrant company’s growth strategyExplosive returns - Jammu Links News
What are the technical indicators suggesting about Cingulate Inc.Uncover the best stocks for explosive growth - Jammu Links News
What is the dividend policy of Cingulate Inc. stockBuild a strong portfolio for growth and safety - Jammu Links News
What makes Cingulate Inc. stock price move sharplyUnlock powerful insights from market experts - Jammu Links News
What catalysts could drive Cingulate Inc. Equity Warrant stock higher in 2025Phenomenal capital appreciation - Jammu Links News
What catalysts could drive Cingulate Inc. stock higher in 2025Double-digit growth - Jammu Links News
What are the technical indicators suggesting about Cingulate Inc. Equity WarrantExplosive wealth accumulation - Jammu Links News
Is Now a Good Time to Reenter Cingulate Inc.Low Risk Picks for Daily Trading Released - metal.it
What are analysts’ price targets for Cingulate Inc. in the next 12 monthsBreakout Stocks Tips That Work - Jammu Links News
What markets is VERB expanding into Is Cingulate Inc. stock a good long term investment optionStock Strategy Entry Points Backed By Experts - jammulinksnews.com
Cingulate gets $4.3M waiver, clearing way to submit for FDA approval - The Business Journals
Analysts Backtest Strategies on Cingulate Inc. Equity Warrant With Promising ResultsHigh Return Conservative Stocks - beatles.ru
How volatile is Cingulate Inc. stock compared to the marketFinancial News Tips To Watch Now - jammulinksnews.com
Cingulate Inc Azioni (CING) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.02%
3.70%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):